FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN

The present invention relates to fibronectin-based scaffold domain proteins that bind to myostatin. The invention also relates to the use of these proteins in therapeutic applications to treat muscular dystrophy, cachexia, sarcopenia, osteoarthritis, osteoporosis, diabetes, obesity, COPD, chronic ki...

Full description

Saved in:
Bibliographic Details
Main Authors ZHAO, Wenjun, LIPOVSEK, Dasa, KRYSTEK, Stanley, Richard, Jr, MADIREDDI, Malavi, WEI, Hui, KOZHICH, Alexander, T, ENGLE, Linda, RAKESTRAW, Ginger, Chao, CORBETT, Martin, J, SWAIN, Joanna, RAMAMURTHY, Vidhyashankar, CLOAD, Sharon, YAMNIUK, Aaron, P
Format Patent
LanguageEnglish
Published 25.02.2022
Subjects
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to fibronectin-based scaffold domain proteins that bind to myostatin. The invention also relates to the use of these proteins in therapeutic applications to treat muscular dystrophy, cachexia, sarcopenia, osteoarthritis, osteoporosis, diabetes, obesity, COPD, chronic kidney disease, heart failure, myocardial infarction, and fibrosis. The invention further relates to cells comprising such proteins, polynucleotides encoding such proteins or fragments thereof, and to vectors comprising the polynucleotides encoding the proteins.
Bibliography:Application Number: MY2019PI03412